Literature DB >> 24828976

Cannabinoids in oral fluid by on-site immunoassay and by GC-MS using two different oral fluid collection devices.

Nathalie A Desrosiers1, Garry Milman, Damodara R Mendu, Dayong Lee, Allan J Barnes, David A Gorelick, Marilyn A Huestis.   

Abstract

Oral fluid (OF) enables non-invasive sample collection for on-site drug testing, but performance of on-site tests with occasional and frequent smokers' OF to identify cannabinoid intake requires further evaluation. Furthermore, as far as we are aware, no studies have evaluated differences between cannabinoid disposition among OF collection devices with authentic OF samples after controlled cannabis administration. Fourteen frequent (≥4 times per week) and 10 occasional (less than twice a week) adult cannabis smokers smoked one 6.8% ∆(9)-tetrahydrocannabinol (THC) cigarette ad libitum over 10 min. OF was collected with the StatSure Saliva Sampler, Oral-Eze, and Draeger DrugTest 5000 test cassette before and up to 30 h after cannabis smoking. Test cassettes were analyzed within 15 min and gas chromatography-mass spectrometry cannabinoid results were obtained within 24 h. Cannabinoid concentrations with the StatSure and Oral-Eze devices were compared and times of last cannabinoid detection (t(last)) and DrugTest 5000 test performance were assessed for different cannabinoid cutoffs. 11-nor-9-Carboxy-THC (THCCOOH) and cannabinol concentrations were significantly higher in Oral-Eze samples than in Stat-Sure samples. DrugTest 5000 t(last) for a positive cannabinoid test were median (range) 12 h (4-24 h) and 21 h (1- ≥ 30 h) for occasional and frequent smokers, respectively. Detection windows in screening and confirmatory tests were usually shorter for occasional than for frequent smokers, especially when including THCCOOH ≥20 ng L(-1) in confirmation criteria. No differences in t(last) were observed between collection devices, except for THC ≥2 μg L(-1). We thus report significantly different THCCOOH and cannabinol, but not THC, concentrations between OF collection devices, which may affect OF data interpretation. The DrugTest 5000 on-site device had high diagnostic sensitivity, specificity, and efficiency for cannabinoids.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24828976      PMCID: PMC4259565          DOI: 10.1007/s00216-014-7813-9

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.142


  25 in total

1.  An analytical evaluation of eight on-site oral fluid drug screening devices using laboratory confirmation results from oral fluid.

Authors:  Tom Blencowe; Anna Pehrsson; Pirjo Lillsunde; Kari Vimpari; Sjoerd Houwing; Beitske Smink; René Mathijssen; Trudy Van der Linden; Sara-Ann Legrand; Kristof Pil; Alain Verstraete
Journal:  Forensic Sci Int       Date:  2010-12-22       Impact factor: 2.395

Review 2.  Blurred boundaries: the therapeutics and politics of medical marijuana.

Authors:  J Michael Bostwick
Journal:  Mayo Clin Proc       Date:  2012-02       Impact factor: 7.616

3.  Evaluation of four oral fluid devices (DDS®, Drugtest 5000®, Drugwipe 5+® and RapidSTAT®) for on-site monitoring drugged driving in comparison with UHPLC-MS/MS analysis.

Authors:  Sabina Strano-Rossi; Erika Castrignanò; Luca Anzillotti; Giovanni Serpelloni; Roberto Mollica; Franco Tagliaro; Jennifer P Pascali; Delfina di Stefano; Roberto Sgalla; Marcello Chiarotti
Journal:  Forensic Sci Int       Date:  2012-05-01       Impact factor: 2.395

4.  Laboratory evaluation and field application of roadside oral fluid collectors and drug testing devices.

Authors:  Dennis J Crouch; J Michael Walsh; Leo Cangianelli; Oscar Quintela
Journal:  Ther Drug Monit       Date:  2008-04       Impact factor: 3.681

5.  An evaluation of selected oral fluid point-of-collection drug-testing devices.

Authors:  Dennis J Crouch; J M Walsh; Ron Flegel; Leo Cangianelli; Jakub Baudys; Randy Atkins
Journal:  J Anal Toxicol       Date:  2005 May-Jun       Impact factor: 3.367

6.  Detection of Delta9-tetrahydrocannabinol and amphetamine-type stimulants in oral fluid using the Rapid Stat point-of-collection drug-testing device.

Authors:  J Röhrich; S Zörntlein; J Becker; R Urban
Journal:  J Anal Toxicol       Date:  2010-04       Impact factor: 3.367

7.  Simultaneous quantification of cannabinoids and metabolites in oral fluid by two-dimensional gas chromatography mass spectrometry.

Authors:  Garry Milman; Allan J Barnes; Ross H Lowe; Marilyn A Huestis
Journal:  J Chromatogr A       Date:  2010-01-04       Impact factor: 4.759

8.  Cannabinoid disposition in oral fluid after controlled cannabis smoking in frequent and occasional smokers.

Authors:  Matthew N Newmeyer; Nathalie A Desrosiers; Dayong Lee; Damodara R Mendu; Allan J Barnes; David A Gorelick; Marilyn A Huestis
Journal:  Drug Test Anal       Date:  2014-03-20       Impact factor: 3.345

9.  Roadside oral fluid testing: comparison of the results of drugwipe 5 and drugwipe benzodiazepines on-site tests with laboratory confirmation results of oral fluid and whole blood.

Authors:  Anna Pehrsson; Teemu Gunnar; Charlotta Engblom; Heikki Seppä; Ahlam Jama; Pirjo Lillsunde
Journal:  Forensic Sci Int       Date:  2007-07-20       Impact factor: 2.395

10.  A placebo-controlled study to assess Standardized Field Sobriety Tests performance during alcohol and cannabis intoxication in heavy cannabis users and accuracy of point of collection testing devices for detecting THC in oral fluid.

Authors:  W M Bosker; E L Theunissen; S Conen; K P C Kuypers; W K Jeffery; H C Walls; G F Kauert; S W Toennes; M R Moeller; J G Ramaekers
Journal:  Psychopharmacology (Berl)       Date:  2012-05-13       Impact factor: 4.530

View more
  8 in total

Review 1.  The state of clinical outcome assessments for cannabis use disorder clinical trials: A review and research agenda.

Authors:  Mallory J E Loflin; Brian D Kiluk; Marilyn A Huestis; Will M Aklin; Alan J Budney; Kathleen M Carroll; Deepak Cyril D'Souza; Robert H Dworkin; Kevin M Gray; Deborah S Hasin; Dustin C Lee; Bernard Le Foll; Frances R Levin; Joshua A Lile; Barbara J Mason; Aimee L McRae-Clark; Ivan Montoya; Erica N Peters; Tatiana Ramey; Dennis C Turk; Ryan Vandrey; Roger D Weiss; Eric C Strain
Journal:  Drug Alcohol Depend       Date:  2020-04-26       Impact factor: 4.492

2.  Quantification of cannabinoids and their free and glucuronide metabolites in whole blood by disposable pipette extraction and liquid chromatography-tandem mass spectrometry.

Authors:  Karl B Scheidweiler; Matthew N Newmeyer; Allan J Barnes; Marilyn A Huestis
Journal:  J Chromatogr A       Date:  2016-05-07       Impact factor: 4.759

3.  Orally administered cannabidiol does not produce false-positive tests for Δ9 -tetrahydrocannabinol on the Securetec DrugWipe® 5S or Dräger DrugTest® 5000.

Authors:  Danielle McCartney; Richard C Kevin; Anastasia S Suraev; Christopher Irwin; Ronald R Grunstein; Camilla M Hoyos; Iain S McGregor
Journal:  Drug Test Anal       Date:  2021-08-30       Impact factor: 3.234

4.  Measuring Within-Individual Cannabis Reduction in Clinical Trials: A Review of the Methodological Challenges.

Authors:  Rachel L Tomko; Kevin M Gray; Marilyn A Huestis; Lindsay M Squeglia; Nathaniel L Baker; Erin A McClure
Journal:  Curr Addict Rep       Date:  2019-11-19

5.  Detection of Δ9 THC in oral fluid following vaporized cannabis with varied cannabidiol (CBD) content: An evaluation of two point-of-collection testing devices.

Authors:  Thomas R Arkell; Richard C Kevin; Jordyn Stuart; Nicholas Lintzeris; Paul S Haber; Johannes G Ramaekers; Iain S McGregor
Journal:  Drug Test Anal       Date:  2019-09-10       Impact factor: 3.345

6.  Effects of Smoking Cannabis on Visual Function and Driving Performance. A Driving-Simulator Based Study.

Authors:  Sonia Ortiz-Peregrina; Carolina Ortiz; José J Castro-Torres; José R Jiménez; Rosario G Anera
Journal:  Int J Environ Res Public Health       Date:  2020-12-03       Impact factor: 3.390

7.  Aggressive Driving Behaviours in Cannabis Users. The Influence of Consumer Characteristics.

Authors:  Sonia Ortiz-Peregrina; Carolina Ortiz; Rosario G Anera
Journal:  Int J Environ Res Public Health       Date:  2021-04-08       Impact factor: 3.390

8.  Preliminary Evidence for Cannabis and Nicotine Urinary Metabolites as Predictors of Verbal Memory Performance and Learning Among Young Adults.

Authors:  Natasha E Wade; Rachel Baca; Kelly E Courtney; Connor J McCabe; M Alejandra Infante; Marilyn A Huestis; Joanna Jacobus
Journal:  J Int Neuropsychol Soc       Date:  2021-07       Impact factor: 2.892

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.